BioMed Research International / 2018 / Article / Fig 2

Research Article

CSF-S100B Is a Potential Candidate Biomarker for Neuromyelitis Optica Spectrum Disorders

Figure 2

Positive correlations between the CSF-S100B or glial fibrillary acidic protein (GFAP) levels and clinical/laboratory findings in neuromyelitis optica spectrum disorder (NMOSD) patients. The CSF-S100B levels correlated with the CSF white blood cell (WBC) count (a), EDSS during attack (b), and during remission (c). The CSF-GFAP levels correlated with the EDSS during remission (d). Statistical testing was performed by using Spearman’s rank correlation analysis. r = Spearman’s rho.
(a)
(b)
(c)
(d)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.